Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants. - Souter V; Johnson L; Becraft E; Cantu-Weinstein A; Tabriziani H; Benn P; Kashtan CE (Journal of genetic counseling, 2025)